Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted therapy for hepatocellular carcinoma
Ao Huang, Xin‐Rong Yang, Wen Yuan Chung, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 529

Showing 1-25 of 529 citing articles:

Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zengfu Zhang, Xu Liu, Dawei Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 336
Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications
Terence K. Lee, Xin‐Yuan Guan, Stephanie Ma
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 19, Iss. 1, pp. 26-44
Closed Access | Times Cited: 313
Targeting the tumor stroma for cancer therapy
Maosen Xu, Tao Zhang, Ruolan Xia, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 154
A Vehicle‐Free Antimicrobial Polymer Hybrid Gold Nanoparticle as Synergistically Therapeutic Platforms for Staphylococcus aureus Infected Wound Healing
Xiaojun He, Lixiong Dai, Lisong Ye, et al.
Advanced Science (2022) Vol. 9, Iss. 14
Open Access | Times Cited: 139
The Landscape Of Alpha Fetoprotein In Hepatocellular Carcinoma: Where Are We?
Xin Hu, Ronggao Chen, Qiang Wei, et al.
International Journal of Biological Sciences (2021) Vol. 18, Iss. 2, pp. 536-551
Open Access | Times Cited: 125
Insights on functionalized carbon nanotubes for cancer theranostics
Lu Tang, Qiaqia Xiao, Yijun Mei, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 115
Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma
Zhuo Yu, Yuyao Li, Yue Li, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 5, pp. e004297-e004297
Open Access | Times Cited: 72
Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies
Changyu Yao, Shilun Wu, Jian Kong, et al.
Cancer Biology and Medicine (2023) Vol. 20, Iss. 1, pp. 25-43
Open Access | Times Cited: 69
A novel polypeptide encoded by the circular RNA ZKSCAN1 suppresses HCC via degradation of mTOR
Runjie Song, Shuoqian Ma, Jiajia Xu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 69
Hepatocellular Carcinoma: a Narrative Review on Current Knowledge and Future Prospects
Basil Alawyia, Constantina Constantinou
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 7, pp. 711-724
Closed Access | Times Cited: 66
NOP2-mediated m5C Modification of c-Myc in an EIF3A-Dependent Manner to Reprogram Glucose Metabolism and Promote Hepatocellular Carcinoma Progression
Hao Zhang, Xiangyu Zhai, Yanfeng Liu, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 51
Hypoxia-responsive PPARGC1A/BAMBI/ACSL5 axis promotes progression and resistance to lenvatinib in hepatocellular carcinoma
Qiangnu Zhang, Lingfeng Xiong, Wei Teng, et al.
Oncogene (2023) Vol. 42, Iss. 19, pp. 1509-1523
Closed Access | Times Cited: 46
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 34
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
Xiaoting Luo, Xin He, Xingmei Zhang, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 30
Ferroptosis: a new hunter of hepatocellular carcinoma
Yulang Jiang, Yongxin Yu, Ziyang Pan, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 20
Proteomic Characterization of Liver Cancer Cells Treated with Clinical Targeted Drugs for Hepatocellular Carcinoma
Hui Long, Jiafu Zhou, Caicun Zhou, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 152-152
Open Access | Times Cited: 1
Hepatocellular Carcinoma in 2021: An Exhaustive Update
Cyriac Abby Philips, S Rajesh, Dinu Chandran Nair, et al.
Cureus (2021)
Open Access | Times Cited: 100
Wnt/β-Catenin Signaling as a Driver of Hepatocellular Carcinoma Progression: An Emphasis on Molecular Pathways
Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, Milad Ashrafizadeh, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 1415-1444
Open Access | Times Cited: 100
The Role of Oxidative Stress in NAFLD–NASH–HCC Transition—Focus on NADPH Oxidases
Daniela Gabbia, Luana Cannella, Sara De Martin
Biomedicines (2021) Vol. 9, Iss. 6, pp. 687-687
Open Access | Times Cited: 74
Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances
Khaled Y. Mahmoud, Shady A. Swidan, Mohamed A. El-Nabarawi, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 64
Immunotherapies for hepatocellular carcinoma
Justin K. H. Liu, Andrew F. Irvine, Rebecca Jones, et al.
Cancer Medicine (2021) Vol. 11, Iss. 3, pp. 571-591
Open Access | Times Cited: 63
Activation of Piezo1 contributes to matrix stiffness‐induced angiogenesis in hepatocellular carcinoma
Miao Li, Xi Zhang, Mimi Wang, et al.
Cancer Communications (2022) Vol. 42, Iss. 11, pp. 1162-1184
Open Access | Times Cited: 59
Embolization therapy with microspheres for the treatment of liver cancer: State-of-the-art of clinical translation
Alexandre Pérez-López, Cristina Martín‐Sabroso, Laura Gómez-Lázaro, et al.
Acta Biomaterialia (2022) Vol. 149, pp. 1-15
Open Access | Times Cited: 54
Anti-cancer activity of sustained release capsaicin formulations
Justin C. Merritt, Stephen D. Richbart, Emily G. Moles, et al.
Pharmacology & Therapeutics (2022) Vol. 238, pp. 108177-108177
Open Access | Times Cited: 50
RNA-binding protein ZCCHC4 promotes human cancer chemoresistance by disrupting DNA-damage-induced apoptosis
Ha Zhu, Kun Chen, Yali Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 48
Page 1 - Next Page

Scroll to top